Literature DB >> 15227171

Systemic antifungal agents.

L O Gentry1.   

Abstract

Year:  1990        PMID： 15227171      PMCID： PMC324917     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  70 in total

1.  Treatment of systemic fungal infections with liposomal amphotericin B.

Authors:  G Lopez-Berestein; G P Bodey; V Fainstein; M Keating; L S Frankel; B Zeluff; L Gentry; K Mehta
Journal:  Arch Intern Med       Date:  1989-11

2.  The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987).

Authors:  K De Beule; P De Doncker; G Cauwenbergh; M Koster; R Legendre; N Blatchford; J Daunas; E Chwetzoff
Journal:  Mycoses       Date:  1988-09       Impact factor: 4.377

3.  Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system.

Authors:  C A Arndt; T J Walsh; C L McCully; F M Balis; P A Pizzo; D G Poplack
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

4.  Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.

Authors:  J R Perfect; D T Durack
Journal:  J Antimicrob Chemother       Date:  1985-07       Impact factor: 5.790

5.  Interaction of cyclosporin and itraconazole.

Authors:  J T Kwan; P J Foxall; D G Davidson; M R Bending; A J Eisinger
Journal:  Lancet       Date:  1987-08-01       Impact factor: 79.321

6.  Itraconazole and cyclosporin nephrotoxicity.

Authors:  I Nováková; P Donnelly; T de Witte; B de Pauw; J Boezeman; G Veltman
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

7.  Intravitreal amphotericin B treatment of Candida endophthamitis.

Authors:  G A Stern; C L Fetkenhour; R B O'Grady
Journal:  Arch Ophthalmol       Date:  1977-01

Review 8.  Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation.

Authors:  R A Branch
Journal:  Arch Intern Med       Date:  1988-11

9.  Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome.

Authors:  A M Sugar; C Saunders
Journal:  Am J Med       Date:  1988-10       Impact factor: 4.965

10.  Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.

Authors:  J J Stern; B J Hartman; P Sharkey; V Rowland; K E Squires; H W Murray; J R Graybill
Journal:  Am J Med       Date:  1988-10       Impact factor: 4.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.